These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Acute myocardial infarction and the use of thrombolytic therapy. Betts B Qld Nurse; 1989; 8(2):12-4. PubMed ID: 2501830 [No Abstract] [Full Text] [Related]
31. [Hemorheological factors in the management of myocardial infarct--use of urokinase]. Kiso T; Harada H; Kawasaki T; Kishima N; Sano I; Fukuda I; Seki I; Mozai T Nihon Rinsho; 1979; 37(2):430-40. PubMed ID: 439432 [No Abstract] [Full Text] [Related]
32. Thrombolytic agents for acute evolving myocardial infarction: comparative effects. Sherry S Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866 [No Abstract] [Full Text] [Related]
33. [Angiographic findings and selective intracoronary thrombolysis in the acute phase of myocardial infarction. Preliminary study and review of the literature]. Espelta FJ; Perez J; Miralles F; Picazo L; Sanz MA; Prieto A; Cozar J; Lopez A Rev Esp Cardiol; 1981; 34(3):201-10. PubMed ID: 7029679 [No Abstract] [Full Text] [Related]
34. Thrombolysis for evolving myocardial infarction. Health and Public Policy Committee, American College of Physicians. Ann Intern Med; 1985 Sep; 103(3):463-9. PubMed ID: 3161441 [No Abstract] [Full Text] [Related]
35. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations. Verstraete M Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745 [No Abstract] [Full Text] [Related]
36. [Basic problems in coronary revascularization]. Biffani G G Ital Cardiol; 1983; 13(4):324-9. PubMed ID: 6224714 [TBL] [Abstract][Full Text] [Related]